Accelr8 Announces Option Exercise to Continue BACcel™ Technology Evaluation

Accelr8 Technology Corporation (NYSE Amex: AXK) announced that it received notification by its industry collaborator of exercise of an option to continue its technology evaluation program for Accelr8's BACcel™ rapid diagnostic system.
See all stories on this topic »